Adagio Medical Holdings (ADGM) Net Cash Flow (2023 - 2026)

Adagio Medical Holdings (ADGM) has 4 years of Net Cash Flow data on file, last reported at -$4.1 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow rose 45.3% year-over-year to -$4.1 million; the trailing twelve-month figure through Mar 2026 stood at -$7.8 million (up 51.21% YoY), and the FY2025 full-year result was -$3.3 million, up 77.94% from the prior year.
• Net Cash Flow retreated to -$4.1 million in Q1 2026, from -$3.6 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $2.7 million in Q1 2024 to a low of -$7.5 million in Q1 2025.
• A 4-year average of -$3.1 million and a median of -$3.6 million in 2025 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow plunged 382.62% in 2025 and surged 45.3% in 2026, its largest moves.
• Tracing ADGM's Net Cash Flow over 4 years: stood at -$533000.0 in 2023, then sank by 1201.31% to -$6.9 million in 2024, then surged by 47.77% to -$3.6 million in 2025, then decreased by 13.94% to -$4.1 million in 2026.
• Business Quant data shows ADGM's Net Cash Flow at -$4.1 million in Q1 2026, -$3.6 million in Q4 2025, and -$7.5 million in Q1 2025.